<DOC>
	<DOCNO>NCT00502463</DOCNO>
	<brief_summary>The purpose trial determine feasibility induction chemotherapy radio-immunotherapy patient head neck cancer stage III/IV</brief_summary>
	<brief_title>Induction Chemotherapy Prior Radio-immunotherapy Head Neck Cancer Stage III/IV - Methodical Trial</brief_title>
	<detailed_description>3 Cycles : Docetaxel 75 mg/m2 d1 , Cisplatin 75 mg/m2 d1 , 5-FU 750 mg/m2 day 1-5 continuous i.v . infusion , Duration 1 cycle : 21 day ; Followed Cetuximab 400 mg/m2 , Start radiotherapy : 1 week first application Cetuximab , During radiotherapy ( 35 x 2 Gy ) : Cetuximab 250 mg/m2 weekly , Up 8 application Cetuximab .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>histologically confirm , locally advanced head neck cancer stage III/IV performance status : ECOG 01 distant metastasis prior radiotherapy head neck region myocardial infarct last six month florid peptic ulcer neuropathy grade III/IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>head neck cancer , stage III/IV</keyword>
	<keyword>prior radiotherapy head neck region</keyword>
</DOC>